Video: Abeona Breaking Into Rare Diseases
This article was originally published in The Pink Sheet Daily
Executive Summary
Abeona Therapeutics CEO Tim Miller explains how his company is poised to enter the clinic with its lead gene therapy programs targeting some devastating lysosomal disease, in an interview at the recent Biotech Showcase.